Suppr超能文献

胃癌的临床病理与免疫组化相关性

Clinical Pathological and Immunohistochemical Correlations in Gastric Cancer.

作者信息

Andronic Mihaela, Scripcariu Dragoș-Viorel, Palaghia Mădălina Maria, Trofin Ana-Maria, Bejan Valentin, Scripcariu Viorel

机构信息

First Surgical Clinic, Saint Spiridon Clinical Hospital, 700111 Iași, Romania.

Surgery Department, Regional Institute of Oncology Iași, 700483 Iasi, Romania.

出版信息

Diagnostics (Basel). 2024 Jun 27;14(13):1367. doi: 10.3390/diagnostics14131367.

Abstract

Due to its high aggressiveness and polyclonal tumor state, stomach cancer is considered a severe health problem. In this study, we analyzed Her2 and Ki67 in correlation with patient data for the possibility of prognostic factors. The study included 48 cases of gastric tumors that had been surgically treated in a period of five years. The percentage was statistically significant for intestinal-type adenocarcinomas located in the medio-gastric region ( = 0.05); in the diffuse subtype, there were no Her2 positive samples, and in the mixed subtype only one out of three samples was Her2 positive. Our results confirm the existing data, and we can conclude that this link can be considered a prognostic factor in the progression and treatment effectiveness.

摘要

由于其高侵袭性和多克隆肿瘤状态,胃癌被认为是一个严重的健康问题。在本研究中,我们分析了Her2和Ki67与患者数据的相关性,以探讨其作为预后因素的可能性。该研究纳入了在五年期间接受手术治疗的48例胃肿瘤病例。位于胃中部的肠型腺癌的百分比具有统计学意义(P = 0.05);在弥漫亚型中,没有Her2阳性样本,在混合亚型中,三个样本中只有一个Her2阳性。我们的结果证实了现有数据,并且我们可以得出结论,这种关联可被视为进展和治疗效果的预后因素。

相似文献

10
Immunohistochemical expression of HER2 in adenocarcinoma of the stomach.HER2在胃腺癌中的免疫组织化学表达
Arq Gastroenterol. 2015 Apr-Jun;52(2):152-5. doi: 10.1590/S0004-28032015000200015.

本文引用的文献

4
Predictive biomarkers in gastric cancer.胃癌的预测生物标志物。
J Cancer Res Clin Oncol. 2023 Jan;149(1):467-481. doi: 10.1007/s00432-022-04408-0. Epub 2022 Oct 19.
6
HER-2 positivity is a high risk of recurrence of stage I gastric cancer.HER-2 阳性是Ⅰ期胃癌复发的高风险因素。
Korean J Intern Med. 2021 Nov;36(6):1327-1337. doi: 10.3904/kjim.2020.243. Epub 2021 Aug 26.
8
Gastric cancer.胃癌。
Lancet. 2020 Aug 29;396(10251):635-648. doi: 10.1016/S0140-6736(20)31288-5.
9
HER2-targeted therapies - a role beyond breast cancer.曲妥珠单抗等 HER2 靶向治疗——超越乳腺癌的应用。
Nat Rev Clin Oncol. 2020 Jan;17(1):33-48. doi: 10.1038/s41571-019-0268-3. Epub 2019 Sep 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验